The president’s advocacy of the anti-malarial drug has created tensions in his administration, and fears among doctors that it could unnecessarily expose patients to risks.
from Health https://ift.tt/2UJebgA
April 06, 2020
Rose
Health, Health - The New York Times
No comments
Related Posts:
How do Moderna’s early results compare with Pfizer’s?Pfizer provided less detail in its announcement last week on Nov. 9 than Moderna did on Monday, Nov. 16. Pfizer’s outside board of experts analyzed 94 volunteers and estimated that the effectiveness of its vaccine was over 90… Read More
Albert R. Jonsen, 89, Dies; Brought Medical Ethics to the BedsideA former Jesuit priest and leader in bioethics, he believed that an ethicist should be part of a patient’s medical team when hard decisions have to be made. from Health https://ift.tt/35B4iXG … Read More
Take the Edge Off With Video GamesUnlike loud, stress-inducing shoot-’em-ups, these ones are meant to calm the mind and offer moments of quiet and clarity. from Health https://ift.tt/2ItFEzG … Read More
Spain’s Other Covid Casualties: Undetected Cancer CasesA raft of lawsuits has emerged from a health care system where the struggle to fight the pandemic has led to neglect of other serious conditions. from Health https://ift.tt/38LALfS … Read More
Is Moderna in Operation Warp Speed?Very much so. The United States government provided $1 billion in support for the design and testing of the Moderna vaccine. Researchers at the National Institutes of Health oversaw much of the research, including the clinica… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment